Mendelian randomisation applied to drug development in cardiovascular disease: a review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mendelian randomisation applied to drug development in cardiovascular disease: a review
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL GENETICS
Volume 52, Issue 2, Pages 71-79
Publisher
BMJ
Online
2014-12-17
DOI
10.1136/jmedgenet-2014-102438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to Letter Regarding Article, “Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)”
- (2014) Amit V. Khera et al. CIRCULATION
- Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis: A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort
- (2014) B. J. Arsenault et al. Circulation-Cardiovascular Genetics
- Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome
- (2014) S. Burgess INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome
- (2014) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ezetimibe Prescribing Fails to Keep Up With Evidence
- (2014) Mike Mitka JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-PCSK9 Monotherapy for Hypercholesterolemia
- (2014) Michael J. Koren et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HDL-targeted therapies: progress, failures and future
- (2014) Bronwyn A. Kingwell et al. NATURE REVIEWS DRUG DISCOVERY
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Statin Alone Versus Bezafibrate and Statin Combination in Patients With Diabetes Mellitus and Acute Coronary Syndrome
- (2013) Robert Klempfner et al. AMERICAN JOURNAL OF CARDIOLOGY
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Secretory Phospholipase A 2 -IIA and Cardiovascular Disease
- (2013) Michael V. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Common variants associated with plasma triglycerides and risk for coronary artery disease
- (2013) Ron Do et al. NATURE GENETICS
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Validating therapeutic targets through human genetics
- (2013) Robert M. Plenge et al. NATURE REVIEWS DRUG DISCOVERY
- HDL—is it too big to fail?
- (2013) Dominic S. Ng et al. Nature Reviews Endocrinology
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Causal Relevance of Blood Lipid Fractions in the Development of Carotid Atherosclerosis
- (2012) Sonia Shah et al. Circulation-Cardiovascular Genetics
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mendelian Randomization: Application to Cardiovascular Disease
- (2011) Nicholas J. Timpson et al. CURRENT HYPERTENSION REPORTS
- Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
- (2011) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II failures: 2008–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Using multiple genetic variants as instrumental variables for modifiable risk factors
- (2011) Tom M Palmer et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Association between Common Variation at the FTO Locus and Changes in Body Mass Index from Infancy to Late Childhood: The Complex Nature of Genetic Association through Growth and Development
- (2011) Ulla Sovio et al. PLoS Genetics
- Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants
- (2010) Brandon L Pierce et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review
- (2009) Samuel Abourbih et al. AMERICAN JOURNAL OF MEDICINE
- Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly
- (2009) Eliana Polisecki et al. JOURNAL OF LIPID RESEARCH
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
- (2008) Alexander Thompson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study
- (2008) Patrick Linsel-Nitschke et al. PLoS One
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now